Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Captopril does not Potentiate Post-Exercise Hypotension: A Randomized Crossover Study

Texto completo
Autor(es):
Mostrar menos -
Carrenho Queiroz, Andreia Cristiane ; Silva Jr Sousa, Julio Cesar ; Silva, Jr., Natan Daniel ; Tobaldini, Eleonora ; Ortega, Katia Coelho ; De Oliveira, Edilamar Menezes ; Brum, Patricia Chakur ; Montano, Nicola ; Mion, Jr., Decio ; Tinucci, Tais ; De Moraes Forjaz, Claudia Lucia
Número total de Autores: 11
Tipo de documento: Artigo Científico
Fonte: INTERNATIONAL JOURNAL OF SPORTS MEDICINE; v. 38, n. 4, p. 270-277, APR 2017.
Citações Web of Science: 4
Resumo

To evaluate whether captopril (3 x 50 mg/day) potentiates post-resistance exercise hypotension (PREH) in hypertensives (HT), 12 HT men received captopril and placebo for 4 weeks each in a double-blinded, randomized-crossover design. On each therapy, subjects underwent 2 sessions: Control (C - rest) and Resistance Exercise (RE - 7 exercises, 3 sets to moderate fatigue, 50 % of 1 RM-repetition maximum). Measurements were taken before and after 30-60 min (Post1) and 7 h (Post2), and ambulatory blood pressure (BP) was monitored for 24 h. There were no differences in PREH characteristics and mechanisms between the placebo and captopril periods. At Post1, systolic/diastolic BP decreased significantly and similarly after RE with both therapies (Placebo = -13 +/- 2/ -9 +/- 1 mmHg vs. Captopril = -12 +/- 2/ -10 +/- 1 mmHg, P < 0.05). RE reduced cardiac output in some subjects and systemic vascular resistance in others. Heart rate and cardiac sympathetic modulation increased, while stroke volume and baroreflex sensitivity decreased after RE (Placebo: + 13 +/- 2 bpm, + 21 +/- 5 nu, -11 +/- 5 ml, -4 +/- 2 ms/mmHg; Captopril: + 13 +/- 2 bpm, + 35 +/- 4 nu, 17 +/- 5 ml, -3 +/- 1 ms/mmHg, P < 0.05). At Post2, all variables returned to pre-intervention values. Ambulatory BP was similar between the sessions. Thus, captopril did not potentiate the magnitude and duration of PREH in HT men, and it did not influence PREH mechanisms. (AU)

Processo FAPESP: 11/06689-5 - Hipotensão pós-exercício resistido em homens hipertensos: influência do uso de captopril
Beneficiário:Cláudia Lúcia de Moraes Forjaz
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 09/18219-3 - Hipotensão pós-exercício resistido em homens hipertensos: influência do uso de captopril.
Beneficiário:Andréia Cristiane Carrenho Queiroz
Modalidade de apoio: Bolsas no Brasil - Doutorado